Provexis PLC (PXS)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.525p
Buy
0.62p
0.00p (+0.00%)
Provexis PLC is engaged in developing and licensing the proprietary Fruitflow, which is a heart-health functional food ingredient for the functional food sector.
Prices updated at 09 May 2025, 16:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
0.62p - 0.54p | |
0.80p - 0.40p | |
- | |
13.44m | |
- | |
750,000 | |
26,954 | |
15.19 | |
824,218.55 | |
0.58 | |
2,217.82m | |
GB00B0923P27 | |
0.00 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.